Literature DB >> 35298355

Multi-modal access method (eye-tracking + switch-scanning) for individuals with severe motor impairment: A preliminary investigation.

S K Fager1, T Sorenson1, E Jakobs2,3, H Koester4, T Jakobs2, D R Beukelman1.   

Abstract

Individuals with severe motor impairments often require alternative means to access computers and communication technology. A range of alternative access devices exist; however, most rely on use of a single access modality. While this approach works for some individuals, it can be limiting for others. This study explored the use of a multi-modal prototype (eye-tracking + switch-scanning) on typing performance with a range of individuals with motor impairments. The multi-modal prototype was compared to eye-tracking alone for this study. Results indicated that the multi-modal prototype had significantly slower typing rate but significantly lower total errors compared to eye-tracking alone. Analysis of individual data revealed four subgroups of clinical relevance including individuals that 1) benefit from multi-modal, 2) benefit from eye-tracking, 3) demonstrate learning and 4) demonstrate fluctuating performance.

Entities:  

Keywords:  alternative access; eye-tracking; scanning; severe motor impairment

Year:  2022        PMID: 35298355      PMCID: PMC9576815          DOI: 10.1080/10400435.2022.2053895

Source DB:  PubMed          Journal:  Assist Technol        ISSN: 1040-0435


  14 in total

1.  Adaptive one-switch row-column scanning.

Authors:  R C Simpson; H H Koester
Journal:  IEEE Trans Rehabil Eng       Date:  1999-12

2.  Access interface strategies.

Authors:  Susan Fager; David R Beukelman; Melanie Fried-Oken; Tom Jakobs; John Baker
Journal:  Assist Technol       Date:  2011

3.  Attention deficit disorder and methylphenidate: a multilevel analysis of dose-response effects on children's impulsivity across settings.

Authors:  M D Rapport; G Stoner; G J DuPaul; K L Kelly; S B Tucker; T Schoeler
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1988-01       Impact factor: 8.829

4.  Telephone talk: effects of two access methods on phone call success.

Authors:  Elizabeth K Hanson; Emily Goldhammer; Tanya Bethard
Journal:  Augment Altern Commun       Date:  2016-07-11       Impact factor: 2.214

5.  Development of the Hearing in Noise Test for the measurement of speech reception thresholds in quiet and in noise.

Authors:  M Nilsson; S D Soli; J A Sullivan
Journal:  J Acoust Soc Am       Date:  1994-02       Impact factor: 1.840

6.  Group-item and directed scanning: examining preschoolers' accuracy and efficiency in two augmentative communication symbol selection methods.

Authors:  Aubrey Randall White; Edward Carney; Joe Reichle
Journal:  Am J Speech Lang Pathol       Date:  2010-07-02       Impact factor: 2.408

7.  Re-designing scanning to reduce learning demands: the performance of typically developing 2-year-olds.

Authors:  John McCarthy; Janice Light; Kathryn Drager; David McNaughton; Laura Grodzicki; Jonathan Jones; Elizabeth Panek; Elizabeth Parkin
Journal:  Augment Altern Commun       Date:  2006-12       Impact factor: 2.214

8.  Exploration of multimodal alternative access for individuals with severe motor impairments: Proof of concept.

Authors:  Kelsey Mandak; Janice Light; Savanna Brittlebank-Douglas
Journal:  Assist Technol       Date:  2021-05-03

9.  SSVEP BCI and Eye Tracking Use by Individuals With Late-Stage ALS and Visual Impairments.

Authors:  Betts Peters; Steven Bedrick; Shiran Dudy; Brandon Eddy; Matt Higger; Michelle Kinsella; Deirdre McLaughlin; Tab Memmott; Barry Oken; Fernando Quivira; Scott Spaulding; Deniz Erdogmus; Melanie Fried-Oken
Journal:  Front Hum Neurosci       Date:  2020-11-20       Impact factor: 3.169

10.  Comparison of eye tracking, electrooculography and an auditory brain-computer interface for binary communication: a case study with a participant in the locked-in state.

Authors:  Ivo Käthner; Andrea Kübler; Sebastian Halder
Journal:  J Neuroeng Rehabil       Date:  2015-09-04       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.